Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 93
Filter
2.
PLoS One ; 16(6): e0251783, 2021.
Article in English | MEDLINE | ID: mdl-34111131

ABSTRACT

In this work, we aimed to develop an automatic algorithm for the quantification of total volume and lung impairments in four different diseases. The quantification was completely automatic based upon high resolution computed tomography exams. The algorithm was capable of measuring volume and differentiating pulmonary involvement including inflammatory process and fibrosis, emphysema, and ground-glass opacities. The algorithm classifies the percentage of each pulmonary involvement when compared to the entire lung volume. Our algorithm was applied to four different patients groups: no lung disease patients, patients diagnosed with SARS-CoV-2, patients with chronic obstructive pulmonary disease, and patients with paracoccidioidomycosis. The quantification results were compared with a semi-automatic algorithm previously validated. Results confirmed that the automatic approach has a good agreement with the semi-automatic. Bland-Altman (B&A) demonstrated a low dispersion when comparing total lung volume, and also when comparing each lung impairment individually. Linear regression adjustment achieved an R value of 0.81 when comparing total lung volume between both methods. Our approach provides a reliable quantification process for physicians, thus impairments measurements contributes to support prognostic decisions in important lung diseases including the infection of SARS-CoV-2.


Subject(s)
Algorithms , COVID-19/diagnostic imaging , Lung/diagnostic imaging , Paracoccidioidomycosis/diagnostic imaging , Pulmonary Disease, Chronic Obstructive/diagnostic imaging , Tomography, X-Ray Computed , Adult , Aged , COVID-19/physiopathology , Female , Humans , Lung/physiopathology , Lung Volume Measurements/methods , Male , Middle Aged , Paracoccidioides/isolation & purification , Paracoccidioidomycosis/physiopathology , Pulmonary Disease, Chronic Obstructive/physiopathology , SARS-CoV-2/isolation & purification , Tomography, X-Ray Computed/methods
3.
Biomed Res Int ; 2019: 8319465, 2019.
Article in English | MEDLINE | ID: mdl-31019973

ABSTRACT

The pathogens Schistosoma mansoni and Paracoccidioides brasiliensis share common geographic areas, determining infectious diseases with high mortality rates worldwide. Histopathological and immunological changes induced by each pathogen are well understood; however, the host responses to S. mansoni and P. brasiliensis coinfection are still unknown. Thus, we investigated liver damage and cytokines production in a murine model acutely and chronically coinfected with these pathogens. Fourty male Swiss mice were infected with S. mansoni and P. brasiliensis alone or coinfected. The animals were euthanized with 50 (acute infection) and 120 (chronic infection) days of infection. All infected animals exhibited liver inflammation. Intense granulomatous inflammation was detected in animals infected with S. mansoni alone and those coinfected. Productive and involutive granulomas were clearly observed in acute and chronic infections, respectively. Granuloma size was reduced in the acute phase and increased in the chronic phase of S. mansoni and P. brasiliensis coinfection, compared with animals infected only with S. mansoni. In the chronic phase of infection, the granulomatous inflammation in coinfected animals was characterized by intense neutrophils accumulation and reduced eosinophils number. IFN-γ, IL-2, IL-4, and IL-5 circulating levels were increased in all infected groups. Coinfected animals presented attenuated IFN-γ and IL-4 production in the acute and chronic infections. Taken together, our findings indicate that coinfected animals exhibited a differential modulation of granulomatous inflammation during the acute and chronic phases of infection, which was potentially associated with a divergent profile of cytokines production and migration of neutrophils and eosinophils in response to S. mansoni and P. brasiliensis antigenic stimulation.


Subject(s)
Coinfection , Granuloma , Liver Diseases , Liver , Paracoccidioides/immunology , Paracoccidioidomycosis , Schistosoma mansoni/immunology , Schistosomiasis mansoni , Animals , Coinfection/immunology , Coinfection/microbiology , Coinfection/parasitology , Coinfection/pathology , Disease Models, Animal , Granuloma/immunology , Granuloma/microbiology , Granuloma/parasitology , Granuloma/pathology , Liver/immunology , Liver/microbiology , Liver/parasitology , Liver/pathology , Liver Diseases/immunology , Liver Diseases/microbiology , Liver Diseases/parasitology , Liver Diseases/pathology , Male , Mice , Paracoccidioidomycosis/immunology , Paracoccidioidomycosis/microbiology , Paracoccidioidomycosis/pathology , Paracoccidioidomycosis/physiopathology , Schistosomiasis mansoni/immunology , Schistosomiasis mansoni/microbiology , Schistosomiasis mansoni/pathology
4.
Mycopathologia ; 183(5): 739-749, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29911286

ABSTRACT

The Notch signaling pathway participates in several cellular functional aspects. This signaling has an important role in targeting both DC maturation and DC-mediated T cell responses. Thus, it is essential to investigate the influence of this signaling pathway in the role played by DCs in the pathogenesis of experimental paracoccidioidomycosis. This disease is a granulomatous and systemic mycosis that mainly affects lung tissue and can spread to any other organ and system. In this study, we demonstrated that bone marrow-derived DCs infected with yeasts from Paracoccidioides brasiliensis strain 18 performed efficiently their maturation after the activation of Notch signaling, with an increase in CD80, CD86, CCR7, and CD40 expression and the release of cytokines such as IL-6 and TNF-α. We observed that the inhibition of the γ-secretase DAPT impaired the proliferation of T cells induced by DC stimulation. In conclusion, our data suggest that Notch signaling contributes effectively to the maturation of DCs and the DC-mediated activation of the T cell response in P. brasiliensis infections.


Subject(s)
Cell Differentiation , Cell Proliferation , Dendritic Cells/physiology , Paracoccidioidomycosis/physiopathology , Receptors, Notch/metabolism , Signal Transduction , T-Lymphocytes/immunology , Animals , Cells, Cultured , Cytokines/metabolism , Female , Membrane Proteins/metabolism , Mice, Inbred BALB C , Paracoccidioides/growth & development
5.
Clin Vaccine Immunol ; 24(11)2017 Nov.
Article in English | MEDLINE | ID: mdl-28903987

ABSTRACT

Heat shock proteins (Hsps) are highly conserved biomolecules that are constitutively expressed and generally upregulated in response to various stress conditions (biotic and abiotic). Hsps have diverse functions, categorizations, and classifications. Their adaptive expression in fungi indicates their significance in these diverse species, particularly in dimorphic pathogens. Histoplasma capsulatum and Paracoccidioides species are dimorphic fungi that are the causative agents of histoplasmosis and paracoccidioidomycosis, respectively. This minireview focuses on the pathobiology of Hsps, with particular emphasis on their roles in the morphogenesis and virulence of Histoplasma and Paracoccidioides and the potential roles of active and passive immunization against Hsps in protection against infection with these fungi.


Subject(s)
Fungal Proteins/physiology , Heat-Shock Proteins/physiology , Histoplasma/pathogenicity , Histoplasmosis/microbiology , Paracoccidioides/pathogenicity , Paracoccidioidomycosis/microbiology , Fungal Proteins/immunology , Heat-Shock Proteins/immunology , Histoplasmosis/physiopathology , Histoplasmosis/therapy , Humans , Immunization, Passive , Immunotherapy , Paracoccidioidomycosis/physiopathology , Paracoccidioidomycosis/therapy , Vaccination , Virulence
6.
Med Mycol ; 55(8): 890-894, 2017 Nov 01.
Article in English | MEDLINE | ID: mdl-28339963

ABSTRACT

Apoptosis is considered an escape mechanism from the host immune system for the fungus Paracoccidioides spp, and it serves as a vehicle for entry into macrophages without stimulating microbicidal activities. Recently, gp43 of P. brasiliensis was demonstrated to be involved in this process. Therefore, as a new therapeutic alternative, it is very important to study compounds that could reduce the modulation of the induction of apoptosis caused by this fungus. Decyl gallate (G14) is a known antifungal compound, and we decided to investigate its anti-apoptotic properties. Our results demonstrate that G14 was effective against apoptosis induced by gp43, as observed in epithelial cells, and led to a reduction in DNA damage, Bak down-regulation and Bcl-2 up-regulation. Together, these data show that G14 presents promising anti-apoptotic activity.


Subject(s)
Antifungal Agents/pharmacology , Apoptosis/drug effects , Glycoproteins/physiology , Paracoccidioides/physiology , A549 Cells , Alveolar Epithelial Cells/microbiology , Alveolar Epithelial Cells/pathology , Antigens, Fungal/metabolism , Cell Line , DNA Damage/drug effects , Fungal Proteins/metabolism , Gene Expression Regulation/drug effects , Genes, bcl-2/genetics , Humans , Paracoccidioidomycosis/physiopathology , bcl-2 Homologous Antagonist-Killer Protein/genetics
7.
Chest ; 151(1): e13-e16, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28065255

ABSTRACT

A 54-year-old French man was admitted for evaluation of a chronic nodular lesion of the tongue and mandibular lymphadenopathy. He reported active tobacco and cannabis smoking as well as excessive alcohol use. He also reported frequent use of cocaine for several months and a past addiction to IV heroin. He had traveled abroad as a journalist and lived for several months in Columbia and Venezuela 12 years ago. His medical history included chronic hepatitis C infection successfully treated with interferon and ribavirin 6 years ago and high BP.


Subject(s)
Granuloma/diagnosis , Itraconazole/administration & dosage , Lymphadenopathy , Multiple Pulmonary Nodules/diagnosis , Paracoccidioidomycosis , Tongue Diseases , Antifungal Agents/administration & dosage , Biopsy/methods , Diagnosis, Differential , Granuloma/etiology , Humans , Lymphadenopathy/diagnosis , Lymphadenopathy/etiology , Male , Middle Aged , Multiple Pulmonary Nodules/etiology , Paracoccidioides/isolation & purification , Paracoccidioidomycosis/complications , Paracoccidioidomycosis/diagnosis , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/physiopathology , Tongue Diseases/etiology , Tongue Diseases/pathology , Treatment Outcome
9.
Medicine (Baltimore) ; 93(25): e167, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25437031

ABSTRACT

This study presents methodology for objectively quantifying the pulmonary region affected by emphysemic and fibrotic sequelae in treated patients with paracoccidioidomycosis. This methodology may also be applied to any other disease that results in these sequelae in the lungs.Pulmonary high-resolution computed tomography examinations of 30 treated paracoccidioidomycosis patients were used in the study. The distribution of voxel attenuation coefficients was analyzed to determine the percentage of lung volume that consisted of emphysemic, fibrotic, and normal tissue. Algorithm outputs were compared with subjective evaluations by radiologists using a scale that is currently used for clinical diagnosis.Affected regions in the patient images were determined by computational analysis and compared with estimates by radiologists, revealing mean (± standard deviation) differences in the scores for fibrotic and emphysemic regions of 0.1% ±â€Š1.2% and -0.2% ±â€Š1.0%, respectively.The computational results showed a strong correlation with the radiologist estimates, but the computation results were more reproducible, objective, and reliable.


Subject(s)
Lung Diseases, Fungal/physiopathology , Lung/diagnostic imaging , Paracoccidioidomycosis/physiopathology , Algorithms , Diagnosis, Computer-Assisted , Emphysema/diagnostic imaging , Fibrosis/diagnostic imaging , Humans , Tomography, X-Ray Computed
10.
Clinics (Sao Paulo) ; 68(4): 441-8, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23778339

ABSTRACT

OBJECTIVES: Chronic paracoccidioidomycosis can diffusely affect the lungs. Even after antifungal therapy, patients may present with residual respiratory abnormalities due to fungus-induced lung fibrosis. METHODS: A cross-sectional analysis of 50 consecutive inactive, chronic paracoccidioidomycosis patients was performed using high resolution computed tomography, pulmonary function tests, ergospirometry, the six-minute walk test and health-related quality of life questionnaires. RESULTS: Radiological abnormalities were present in 98% of cases, the most frequent of which were architectural distortion (90%), reticulate and septal thickening (88%), centrilobular and paraseptal emphysema (84%) and parenchymal bands (74%). Patients typically presented with a mild obstructive disorder and a mild reduction in diffusion capacity with preserved exercise capacity, including VO2max and six-minute walking distance. Patient evaluation with the Saint-George Respiratory Questionnaire showed low impairment in the health-related quality of life, and the Medical Research Council questionnaire indicated a low dyspnea index. There were, however, patients with significant oxygen desaturation upon exercise that was associated with respiratory distress compared with the non-desaturated patients. The initial counterimmunoelectrophoresis of these patients was higher and lung emphysema was more prominent; however, there were no differences in the interstitial fibrotic tomographic abnormalities, tobacco exposure, functional responses, exercise capacity or quality of life. CONCLUSIONS: Inactive, chronic paracoccidioidomycosis patients show persistent and disseminated radiological abnormalities by high resolution computed tomography, short impairments in pulmonary function and low impacts on aerobic capacity and quality of life. However, there was a subset of individuals whose functional impairment was more severe. These patients present with higher initial serology and more severe emphysema, stressing the importance of adequate treatment associated with tobacco exposure cessation.


Subject(s)
Lung/physiopathology , Paracoccidioidomycosis/physiopathology , Adult , Aged , Cross-Sectional Studies , Epidemiologic Methods , Female , Fibrosis/microbiology , Fibrosis/pathology , Fibrosis/physiopathology , Humans , Lung/microbiology , Lung/pathology , Male , Middle Aged , Oxygen Consumption/physiology , Paracoccidioidomycosis/pathology , Quality of Life , Respiratory Function Tests , Smoking/adverse effects , Time Factors , Tomography, X-Ray Computed
11.
Clinics ; 68(4): 441-448, abr. 2013. tab, graf
Article in English | LILACS | ID: lil-674238

ABSTRACT

OBJECTIVES: Chronic paracoccidioidomycosis can diffusely affect the lungs. Even after antifungal therapy, patients may present with residual respiratory abnormalities due to fungus-induced lung fibrosis. METHODS: A cross-sectional analysis of 50 consecutive inactive, chronic paracoccidioidomycosis patients was performed using high resolution computed tomography, pulmonary function tests, ergospirometry, the six-minute walk test and health-related quality of life questionnaires. RESULTS: Radiological abnormalities were present in 98% of cases, the most frequent of which were architectural distortion (90%), reticulate and septal thickening (88%), centrilobular and paraseptal emphysema (84%) and parenchymal bands (74%). Patients typically presented with a mild obstructive disorder and a mild reduction in diffusion capacity with preserved exercise capacity, including VO2max and six-minute walking distance. Patient evaluation with the Saint-George Respiratory Questionnaire showed low impairment in the health-related quality of life, and the Medical Research Council questionnaire indicated a low dyspnea index. There were, however, patients with significant oxygen desaturation upon exercise that was associated with respiratory distress compared with the non-desaturated patients. The initial counterimmunoelectrophoresis of these patients was higher and lung emphysema was more prominent; however, there were no differences in the interstitial fibrotic tomographic abnormalities, tobacco exposure, functional responses, exercise capacity or quality of life. CONCLUSIONS: Inactive, chronic paracoccidioidomycosis patients show persistent and disseminated radiological abnormalities by high resolution computed tomography, short impairments in pulmonary function and low impacts on aerobic capacity and quality of life. However, there was a subset of individuals whose functional impairment was more severe. These patients present with higher initial ...


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Lung/physiopathology , Paracoccidioidomycosis/physiopathology , Cross-Sectional Studies , Epidemiologic Methods , Fibrosis/microbiology , Fibrosis/pathology , Fibrosis/physiopathology , Lung/microbiology , Lung/pathology , Oxygen Consumption/physiology , Paracoccidioidomycosis/pathology , Quality of Life , Respiratory Function Tests , Smoking/adverse effects , Time Factors , Tomography, X-Ray Computed
12.
Microbes Infect ; 14(6): 517-27, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22281666

ABSTRACT

Paracoccidioidomycosis is a systemic granulomatous disease caused by the dimorphic fungus Paracoccidioides brasiliensis. Its major antigen is a 43 kDa glycoprotein whose peptides embody different functions: P10 peptide, a T-cell epitope, induces protective response while P4 and P23 peptides inhibit both, macrophage functions and inflammatory reaction, thus facilitating infection. Here we investigated the modulating mechanisms of the immune response exerted by P4 and P23 involved in the latter inhibitory effect on macrophages. Moreover we analyzed the peptides effects in different models in vivo. While evaluating whether P4 and P23 present systemic anti-inflammatory effects in vivo, we showed that their intraperitonial administration decreased footpad swelling in mice infected with either P. brasiliensis or Mycobacterium bovis. Both, qPCR and ELISA assays suggested that this anti-inflammatory effect depended on alterations in the kinetics of production of innate immunity modulators such as TNF-α, IL6, IL10 and TLR2. IL10 seems to be early produced than TNF-α and IL6, produced later in presence of peptides. Higher doses or intravenously given P4 and P23 resulted in earlier and more prolonged anti-inflammatory effects. Moreover, continuous treatment with P4 and P23 sustained the anti-inflammatory activity throughout.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Antigens, Fungal/chemistry , Fungal Proteins/chemistry , Glycoproteins/chemistry , Inflammation/drug therapy , Paracoccidioides/pathogenicity , Paracoccidioidomycosis/drug therapy , Peptides/therapeutic use , Amino Acid Sequence , Animals , Anti-Inflammatory Agents/pharmacology , Cytokines/immunology , Cytokines/metabolism , Foot/microbiology , Inflammation/immunology , Inflammation/microbiology , Macrophages/drug effects , Macrophages/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Molecular Sequence Data , Paracoccidioides/drug effects , Paracoccidioidomycosis/immunology , Paracoccidioidomycosis/microbiology , Paracoccidioidomycosis/physiopathology , Peptides/chemical synthesis , Peptides/chemistry , Peptides/pharmacology
13.
Semin Respir Crit Care Med ; 32(6): 764-74, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22167404

ABSTRACT

Paracoccidioidomycosis is a subacute or chronic systemic mycosis caused by Paracoccidioides brasiliensis, a soil saprophyte and thermally dimorphic fungus. The disease occurs mainly in rural workers in Latin America and is the most frequent endemic systemic mycosis in many countries of South America, where almost 10 million people are believed to be infected. Paracoccidioidomycosis should be regarded as a disease of travelers outside the endemic area. The primary pulmonary infection is subclinical in most cases, and individuals may remain infected throughout life without ever developing clinical signs. A small proportion of patients present with clinical disease. The lungs are frequently involved, and the pulmonary clinical manifestations must be differentiated from many other infectious and noninfectious conditions. Diagnosis should be based on epidemiological, clinical, and microbiological data. Effective treatment regimens are available to control the fungal infection, but most patients develop fibrotic sequelae that may severely hamper respiratory and adrenal function and the patient's well-being.


Subject(s)
Lung Diseases, Fungal , Paracoccidioides/pathogenicity , Paracoccidioidomycosis , Antifungal Agents/therapeutic use , Humans , Latin America/epidemiology , Lung Diseases, Fungal/diagnosis , Lung Diseases, Fungal/drug therapy , Lung Diseases, Fungal/epidemiology , Lung Diseases, Fungal/physiopathology , Paracoccidioides/cytology , Paracoccidioides/immunology , Paracoccidioidomycosis/diagnosis , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/epidemiology , Paracoccidioidomycosis/physiopathology
14.
J Clin Gastroenterol ; 45(2): 87-91, 2011 Feb.
Article in English | MEDLINE | ID: mdl-20975575

ABSTRACT

Paracoccidioidomycosis is the most prevalent mycosis in Latin America. Although the lungs are the primary site of infection, physicians often see patients because of disseminated disease. Imported paracoccidioidomycosis has been described in different regions of the world in patients who lived in endemic areas. Gastrointestinal disease owing to P. brasiliensis is rarely recognized in life because of nonspecific clinical manifestations. Gastrointestinal disease can present as part of progressive dissemination of infection or as a result of local complications from a silent healing process. This review will summarize the salient features of gastrointestinal paracoccidioidomycosis.


Subject(s)
Gastrointestinal Diseases/epidemiology , Adult , Antifungal Agents/therapeutic use , Female , Gastrointestinal Diseases/drug therapy , Gastrointestinal Diseases/microbiology , Gastrointestinal Diseases/physiopathology , Gastrointestinal Tract/microbiology , Humans , Male , Middle Aged , Paracoccidioides/drug effects , Paracoccidioides/pathogenicity , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/epidemiology , Paracoccidioidomycosis/microbiology , Paracoccidioidomycosis/physiopathology
15.
Am J Trop Med Hyg ; 83(1): 111-4, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20595488

ABSTRACT

This study assessed adrenal function in patients with paracoccididioidomycosis who had been treated to determine a possible connection between high antibody titers and adrenal dysfunction attributable to persistence of the fungus in adrenal gland. Adrenal gland function was studied in 28 previously treated patients, 2 (7.1%) of whom were shown to have adrenal insufficiency and 7 (259%) who showed a below normal response to stimuli by adrenocorticotropic hormone. Paracoccidioides brasiliensis was detected in the adrenal gland from one of the patients with adrenal insufficiency. Although the study failed to demonstrate a significant difference between high antibody titers and low cortisol levels, the proportion of adrenal insufficiency detected and the subnormal response to adrenocorticotropic hormone confirmed that adrenal damage is an important sequela of paracoccidioidomycosis. Studies with a larger number of patients should be conducted to confirm the hypothesis of persistence of P. brasiliensis in adrenal gland after therapy.


Subject(s)
Adrenal Glands/drug effects , Adrenal Insufficiency/chemically induced , Drug Therapy, Combination/adverse effects , Hydrocortisone/toxicity , Paracoccidioides/drug effects , Paracoccidioidomycosis/physiopathology , Adrenal Glands/physiopathology , Adrenal Insufficiency/etiology , Algorithms , Follow-Up Studies , Humans , Paracoccidioidomycosis/drug therapy
16.
Cytokine ; 48(3): 212-7, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19682920

ABSTRACT

The gene polymorphisms interferon-gamma (IFN-gamma) +874 T/A and interleukin (IL)-4 -590 C/T have been associated with the altered production of cytokines. Therefore, they might be indicative of the occurrence of Paracoccidioidomycosis (PCM) caused by Paracoccidioides brasiliensis. The analysis of single nucleotide polymorphism (SNP) at position+874 IFN-gamma showed an increase occurrence of A/T genotype in both PCM patients and healthy individuals as control (HIC) (56% and 45%, respectively), while the allelic distribution showed 82% of A allele in the patients and 80% in the controls. The SNP of -590 IL-4 showed that C/T genotype was significantly (p<0.05) more prevalent (39%) in PCM group compared to the HIC group (19%), while IL-4 C/C genotype was significantly less frequent (59%) in the patient group compared to the control group (81%). Otherwise, 41% of PCM patients and 19% of HIC individuals carried the IL-4 T allele. Stimulation of peripheral blood mononuclear cells (PBMC) from PCM patients with cell extract antigenic preparations (PbAg) as well as secreted and surface antigens (MEXO) of P. brasiliensis evidenced that there is no difference in the IFN-gamma production related to A and T alleles between PCM and HIC individuals. However, with IL-4 production, PCM patients classified as C phenotype showed two times more IL-4 production than PCM patients classified as T phenotype and HIC controls. In conclusion, our results suggest that functional genetic variants in the IL-4 promoter could influence the production of IL-4 in PCM.


Subject(s)
Interferon-gamma/genetics , Interleukin-4/genetics , Paracoccidioidomycosis/genetics , Polymorphism, Single Nucleotide , Adolescent , Adult , Aged , Antigens, Fungal/pharmacology , Gene Expression Regulation/drug effects , Genetic Predisposition to Disease , Humans , Immunity, Innate , Interferon-gamma/metabolism , Interleukin-4/metabolism , Male , Middle Aged , Paracoccidioides/immunology , Paracoccidioidomycosis/immunology , Paracoccidioidomycosis/physiopathology , Young Adult
18.
Mycopathologia ; 167(2): 89-93, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18781395

ABSTRACT

OBJECTIVE: In order to describe the case of an adolescent who developed psoas abscesses caused by Paracoccidiodes brasiliensis. DESCRIPTION: A 12-year-old boy was admitted with a history of daily fever and global lymph nodes enlargement. He had been treated in the last 6 years, with irregular use of the drugs, for an acute form of paracoccidioidomycosis (PCM). He presented a tenderness fluctuating polyadenopathy in all cervical, submandibular, supraclavicular, axillary, and inguinal chains; several lymph nodes were up to 4 cm in diameter, hardened and coalescent. After 1 month of unsuccessful therapy with SMX-TMP, the patient presented a pain in the right groin and difficulty to walk. CT scan showed a global retroperitoneal lymph nodes enlargement, some with central necrosis and two bigger collections adjacent to both psoas muscles. A surgical drainage of the collections was performed for several times. The patient received a total of 1.9 g of Amphotericin B. After 1 month of the last surgical procedure, CT scan showed only a residual collection, and the patient was sent to ambulatory follow-up. We hypothesed that the retroperitoneal lymph nodes became a coalescent mass that fistulized to the psoas compartment. COMMENTS: The patient presented a febrile lymphoproliferative syndrome that is frequently seen in children with PCM. Although a polymorphic manifestation is observed in this disease, psoas abscess is a rare complication of PCM. The health professionals that take care of the patients with PCM must pay attention to the possibility of this one more complication.


Subject(s)
Paracoccidioidomycosis/complications , Psoas Abscess/etiology , Adolescent , Amphotericin B/therapeutic use , Antifungal Agents/administration & dosage , Antifungal Agents/therapeutic use , Child , Directly Observed Therapy , Fever , Humans , Infusions, Intravenous , Itraconazole/administration & dosage , Itraconazole/therapeutic use , Lymph Nodes/diagnostic imaging , Male , Paracoccidioides/isolation & purification , Paracoccidioidomycosis/drug therapy , Paracoccidioidomycosis/physiopathology , Patient Compliance , Psoas Abscess/diagnostic imaging , Psoas Abscess/drug therapy , Psoas Abscess/surgery , Radiography , Trimethoprim, Sulfamethoxazole Drug Combination/administration & dosage , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
19.
In. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Guia de vigilância epidemiológica. Brasília, Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica, 7 ed; 2009. p.1-60, ilus, tab, graf, map. (A. Normas e Manuais Técnicos).
Monography in Portuguese | LILACS, Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1247192
SELECTION OF CITATIONS
SEARCH DETAIL
...